Devices › Immunoassay method, troponin subunit
Device brand name · Immunoassay method troponin subunit
Access Accutni+3 Reagent: medical device reports filed with FDA
600 reports name it, 2014–2025. Manufacturer given most often on reports: Beckman Coulter. Product code MMI.
- 600
- device reports naming the brand
- 0% of all MAUDE reports · about 49 a year
- 4
- reports, 12 months to August 2026
- 0 in the 12 months before
- 58.8%
- classified as malfunction
- 87.4% across the product code
- 0%
- classified as death, as reported
- 0 reports · not verified by FDA
600 medical device reports received by FDA name the brand "Access Accutni+3 Reagent" (immunoassay method troponin subunit); the manufacturer given most often on reports is Beckman Coulter; received from March 2014 to October 2025. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.
4 reports arrived in the 12 months to August 2026, with none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (58.8%) and injury (41%); across all immunoassay method, troponin subunit reports (product code MMI) death is recorded in 0.1% and malfunction in 87.4%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are high test results (60.3%), incorrect, inadequate or imprecise result or readings (19.7%) and incorrect or inadequate test results (13.3%). The patient problems coded most often are misdiagnosis, test result and venipuncture. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 18,167 reports carrying product code MMI. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| High test results | 362 | 60.3% | 60.3% |
| Incorrect, inadequate or imprecise result or readings | 118 | 19.7% | 3% |
| Incorrect or inadequate test results | 80 | 13.3% | 13.6% |
| False positive result | 17 | 2.8% | 13.3% |
| Incorrect measurementthe device measured wrongly | 7 | 1.2% | 0.5% |
| Low test results | 2 | 0.3% | 4.6% |
| Calibration problem | 1 | 0.2% | 0.2% |
| Device contamination with chemical or other material | 1 | 0.2% | 0% |
| Device handling problem | 1 | 0.2% | 0% |
| Device operates differently than expectedthe device behaved unexpectedly | 1 | 0.2% | 0.3% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Misdiagnosis | 8 | 1.3% |
| Test result | 4 | 0.7% |
| Venipuncture | 3 | 0.5% |
| Complaint, ill-defined | 2 | 0.3% |
| Chest painchest pain | 1 | 0.2% |
| Embolism | 1 | 0.2% |
| Inflammationinflammation | 1 | 0.2% |
| Injurya physical injury | 1 | 0.2% |
| Myocardial infarctionheart attack | 1 | 0.2% |
| Pneumonialung infection | 1 | 0.2% |
| Thrombus | 1 | 0.2% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Access Accutni+3 Reagent | Product code MMI | All MAUDE reports |
|---|---|---|---|
| Reports | 600 | 18,167 | 26,136,888 |
| Share of that pool | — | 3.3% | 0% |
| Classified as death, per 1,000 reports | 0 | 1 | 9 |
| Classified as injury | 41% | 8.6% | 36.2% |
| Classified as malfunction | 58.8% | 87.4% | 62.3% |
| Filed by the manufacturer | 99.8% | 99.6% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code MMI
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Access 2 Immunoassay System | 4,719 | 0 | 0% |
| I-Stat Troponin Ctni Cartridge | 1,332 | 28 | 0% |
| Dimension Clinical Chemistry System | 1,895 | 0 | 0.2% |
| ARCHITECT STAT Troponin-I | 975 | 25 | 0.3% |
| VITROS Immunodiagnostic Products Troponin I ES Reagent Pack | 892 | 52 | 0% |
| UniCel DxC 600i SYNCHRON Access Clinical System | 2,975 | 13 | 0% |
| Elecsys Troponin T hs | 670 | 136 | 0% |
| ARCHITECT STAT High Sensitive Troponin-I | 502 | 59 | 0% |
| Alinity i STAT High Sensitive Troponin-I Reagent Kit | 452 | 147 | 0% |
| Unicel Dxi 800 Access Immunoassay System | 3,133 | 0 | 0% |
| Atellica IM High-Sensitivity Troponin I (TnIH) | 372 | 46 | 0% |
| Access Accutni | 281 | 0 | 0% |
| Architect Stat Troponin-I Reagent Kit | 249 | 0 | 0% |
| Atellica Im High Sensitivity Troponin I Tnih Assay | 222 | 0 | 0% |
| Dimension | 1,139 | 40 | 0.1% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Access Accutni+3 Reagent reports
How many FDA reports name Access Accutni+3 Reagent?
600 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 4 in the latest 12 months.
What kinds of events are reported?
malfunction (58.8%) and injury (41%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
high test results (60.3%), incorrect, inadequate or imprecise result or readings (19.7%), incorrect or inadequate test results (13.3%), false positive result (2.8%) and incorrect measurement (1.2%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (99.8%) and voluntary reports (0.2%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Access Accutni+3 Reagent was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.